150 related articles for article (PubMed ID: 38316068)
1. FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53-P21/Nrf2 activation in a HuR-dependent m6A manner.
Yang Y; Ren J; Zhang J; Shi H; Wang J; Yan Y
Redox Biol; 2024 Apr; 70():103067. PubMed ID: 38316068
[TBL] [Abstract][Full Text] [Related]
2. Activation of p62-NRF2 Axis Protects against Doxorubicin-Induced Ferroptosis in Cardiomyocytes: A Novel Role and Molecular Mechanism of Resveratrol.
Yu W; Chen C; Xu C; Xie D; Wang Q; Liu W; Zhao H; He F; Chen B; Xi Y; Yan Y; Yu L; Cheng J
Am J Chin Med; 2022; 50(8):2103-2123. PubMed ID: 36309811
[TBL] [Abstract][Full Text] [Related]
3. Cardiac sirtuin1 deficiency exacerbates ferroptosis in doxorubicin-induced cardiac injury through the Nrf2/Keap1 pathway.
Wang W; Zhong X; Fang Z; Li J; Li H; Liu X; Yuan X; Huang W; Huang Z
Chem Biol Interact; 2023 May; 377():110469. PubMed ID: 37030624
[TBL] [Abstract][Full Text] [Related]
4. Dihydroartemisinin alleviates doxorubicin-induced cardiotoxicity and ferroptosis by activating Nrf2 and regulating autophagy.
Lin ZH; Xiang HQ; Yu YW; Xue YJ; Wu C; Lin C; Ji KT
FASEB J; 2024 May; 38(10):e23677. PubMed ID: 38775792
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen sulfide protects cardiomyocytes from doxorubicin-induced ferroptosis through the SLC7A11/GSH/GPx4 pathway by Keap1 S-sulfhydration and Nrf2 activation.
Zhang H; Pan J; Huang S; Chen X; Chang ACY; Wang C; Zhang J; Zhang H
Redox Biol; 2024 Apr; 70():103066. PubMed ID: 38359744
[TBL] [Abstract][Full Text] [Related]
6. FTO inhibits oxidative stress by mediating m6A demethylation of Nrf2 to alleviate cerebral ischemia/reperfusion injury.
Hou L; Li S; Li S; Wang R; Zhao M; Liu X
J Physiol Biochem; 2023 Feb; 79(1):133-146. PubMed ID: 36327034
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of METTL3 ameliorates doxorubicin-induced cardiotoxicity through suppression of TFRC-mediated ferroptosis.
Wu L; Du Y; Wang L; Zhang Y; Ren J
Redox Biol; 2024 Jun; 72():103157. PubMed ID: 38631119
[TBL] [Abstract][Full Text] [Related]
8. FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner.
Ji FH; Fu XH; Li GQ; He Q; Qiu XG
Front Endocrinol (Lausanne); 2022; 13():857765. PubMed ID: 35721711
[TBL] [Abstract][Full Text] [Related]
9. FTO-Dependent N
Mathiyalagan P; Adamiak M; Mayourian J; Sassi Y; Liang Y; Agarwal N; Jha D; Zhang S; Kohlbrenner E; Chepurko E; Chen J; Trivieri MG; Singh R; Bouchareb R; Fish K; Ishikawa K; Lebeche D; Hajjar RJ; Sahoo S
Circulation; 2019 Jan; 139(4):518-532. PubMed ID: 29997116
[TBL] [Abstract][Full Text] [Related]
10. Activation of AMPKα2 attenuated doxorubicin-induced cardiotoxicity via inhibiting lipid peroxidation associated ferroptosis.
Liao HH; Ding W; Zhang N; Zhou ZY; Ling Z; Li WJ; Chen S; Tang QZ
Free Radic Biol Med; 2023 Aug; 205():275-290. PubMed ID: 37331642
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen sulfide alleviates mitochondrial damage and ferroptosis by regulating OPA3-NFS1 axis in doxorubicin-induced cardiotoxicity.
Wang Y; Ying X; Wang Y; Zou Z; Yuan A; Xiao Z; Geng N; Qiao Z; Li W; Lu X; Pu J
Cell Signal; 2023 Jul; 107():110655. PubMed ID: 36924813
[TBL] [Abstract][Full Text] [Related]
12. Pinocembrin inhibited cardiomyocyte pyroptosis against doxorubicin-induced cardiac dysfunction via regulating Nrf2/Sirt3 signaling pathway.
Gu J; Huang H; Liu C; Jiang B; Li M; Liu L; Zhang S
Int Immunopharmacol; 2021 Jun; 95():107533. PubMed ID: 33752080
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin agonist ADP355 ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and oxidative stress.
Zhao D; Xue C; Li J; Feng K; Zeng P; Chen Y; Duan Y; Zhang S; Li X; Han J; Yang X
Biochem Biophys Res Commun; 2020 Dec; 533(3):304-312. PubMed ID: 32958254
[TBL] [Abstract][Full Text] [Related]
14. FTO-Nrf2 axis regulates bisphenol F-induced leydig cell toxicity in an m6A-YTHDF2-dependent manner.
Zhou SM; Li JZ; Chen HQ; Zeng Y; Yuan WB; Shi Y; Wang N; Fan J; Zhang Z; Xu Y; Cao J; Liu WB
Environ Pollut; 2023 May; 325():121393. PubMed ID: 36878272
[TBL] [Abstract][Full Text] [Related]
15. Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway.
Cheng Y; Wu X; Nie X; Wu Y; Zhang C; Lee SM; Lv K; Leung GP; Fu C; Zhang J; Li J
Phytomedicine; 2022 Nov; 106():154407. PubMed ID: 36070662
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis as a target for protection against cardiomyopathy.
Fang X; Wang H; Han D; Xie E; Yang X; Wei J; Gu S; Gao F; Zhu N; Yin X; Cheng Q; Zhang P; Dai W; Chen J; Yang F; Yang HT; Linkermann A; Gu W; Min J; Wang F
Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2672-2680. PubMed ID: 30692261
[TBL] [Abstract][Full Text] [Related]
17. Orosomucoid 1 Attenuates Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling.
Cheng X; Liu D; Xing R; Song H; Tian X; Yan C; Han Y
Biomed Res Int; 2020; 2020():5923572. PubMed ID: 33134382
[TBL] [Abstract][Full Text] [Related]
18. Exploring the role of ferroptosis in the doxorubicin-induced chronic cardiotoxicity using a murine model.
Li X; Liang J; Qu L; Liu S; Qin A; Liu H; Wang T; Li W; Zou W
Chem Biol Interact; 2022 Aug; 363():110008. PubMed ID: 35667395
[TBL] [Abstract][Full Text] [Related]
19. Aloe-emodin alleviates doxorubicin-induced cardiotoxicity via inhibition of ferroptosis.
He Y; Xi J; Fang J; Zhang B; Cai W
Free Radic Biol Med; 2023 Sep; 206():13-21. PubMed ID: 37364691
[TBL] [Abstract][Full Text] [Related]
20. LCZ696 protects against doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via AKT/SIRT3/SOD2 signaling pathway activation.
Liu X; Li D; Pi W; Wang B; Xu S; Yu L; Yao L; Sun Z; Jiang J; Mi Y
Int Immunopharmacol; 2022 Dec; 113(Pt A):109379. PubMed ID: 36330913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
